Fredun Pharmaceuticals has established a new manufacturing facility in Palghar, Maharashtra, marking the addition of its fifth facility. This marks a significant step in the company’s expansion journey. The facility is expected to be operational by October 2026.
The company remains committed to maintaining high standards of quality, compliance, and innovation while strengthening its position as a leading manufacturing partner in the healthcare industry.
Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1874.60 |
| Dr. Reddys Lab | 1293.90 |
| Cipla | 1314.55 |
| Zydus Lifesciences | 947.25 |
| Lupin | 2270.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: